A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
Clinical trial NCT06564311 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06564311
- Sponsor
- Zenas BioPharma (USA), LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-26
- Primary completion
- 2025-08-28
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.